Private Markets Newswire · 09 Apr 2026
Oxford–Cambridge Deal Flow: Six Investments Shaping the Corridor's Next Chapter
From a £65 million Series A advancing amyloidosis therapy to a Cambridge spin-out developing brain-inspired AI chip materials, Private Markets Group rounds up the most significant recent investment activity across the Oxford–Cambridge innovation corridor.
Read full coverage on source website →